This study has two parts. The main objective of part 1 (in vivo) is todetermine changes in markers of oxidative stress in exhaled breath as a result of different short term oxygenation strategies (liberal versus conservative) . The main objective of…
ID
Source
Brief title
Condition
- Viral infectious disorders
- Lower respiratory tract disorders (excl obstruction and infection)
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The main study parameters of part 1) are markers of oxidative stress as
measured by volatile organic compounds from exhaled breath in vivo. The main
study parameters of part 2) are markers of oxidative stress and cellular
injury in vitro.
Secondary outcome
na
Background summary
Severe viral lower respiratory tract infection (VLRTI) is the most common
reason for pediatric intensive care unit admission and forms a major healthcare
burden worldwide. Children with severe VLRTI are commonly treated with both
non-invasive and invasive (mechanical ventilation) oxygen therapy due to
hypoxia. However, optimal oxygen saturation targets in critically-ill children
are currently unknown. In comparison, in adults there is also an ongoing debate
regarding saturation targets and whether supplemental oxygen (hyperoxia) should
be kept to a minimum (conservative oxygenation) or can be given more liberal.
The basis for this discussion is that hyperoxia may increase the production of
reactive oxygen species, which could induce oxidative stress and lung
epithelial injury. At present, there is no evidence on whether or not
conservative oxygenation can reduce oxidative stress compared to liberal
oxygenation in children, in particular not in the setting of a pro-inflammatory
pulmonary micro-environment (e.g. due to VLRTI). Measurement of volatile
organic compounds in exhaled breath can be used as a non-invasive, easy
obtainable marker for oxidative stress in vivo in patients receiving oxygen
therapy. In addition, in vitro epithelial cell based systems can assess the
effects of oxygen therapy on the lung micro-environment level.
In this study, short term conservative oxygenation is hypothesized to reduce
markers of oxidative stress in exhaled breath in comparison with short term
liberal oxygenation. Secondly, as compared to hyperoxia, normoxic conditions is
hypothesized to reduce oxidative stress and injury of lung epithelial cells in
a pro-inflammatory micro-environment in vitro.
Study objective
This study has two parts. The main objective of part 1 (in vivo) is todetermine
changes in markers of oxidative stress in exhaled breath as a result of
different short term oxygenation strategies (liberal versus conservative) . The
main objective of part 2 (in vitro) is to assess differences in makers of
oxidative stress and lung epithelial cell injury after prolonged hyperoxic
versus normoxic conditions in the setting of a pro-inflammatory
micro-environment in vitro.
Study design
This will be a randomized cross-over study of two different short term
oxygenation protocols (liberal and conservative) during ongoing mechanical
ventilation as part of usual clinical care.
Intervention
No investigational product is administered. Two short term oxygenation
protocols will be used during ongoing mechanical ventilation as part of usual
clinical care.
Study burden and risks
Patients with VLRTI who will participate in this study will undergo two short
term oxygenation protocols (3 hours) as an adaption of usual clinical care on
two separate days. On both days, non-invasive exhaled breath samples will be
collected five times, and on the third day one blind non-bronchoscopic lavage
(mini-BAL) will be performed. Patients without VLRTI who will participate in
this study will undergo one short term oxygenation protocol (3 hours) as an
adaption of usual clinical care on a single day, upon which non-invasive
exhaled breath samples will be collected five times.
The expected physical discomfort associated with participation in this study is
minimal as patients will be sedated for the entire duration of the study
protocol as part of usual clinical care. Therefore patients will be unaware of
the study procedures. The risks with participation in this study are expected
to be minimal, as the brief adaption of usual clinical care is not expected to
have any detrimental or lasting effects on the patients. The study
(non-invasive and single invasive) procedures used to obtain data are also
expected to impose minimal risks. No direct benefit for the patient comes from
participation in this study, however, it is expected that the results from this
study will benefit the specific patient population and future patients. As
mechanical ventilation is not part of clinical care for non-critically ill
children and data regarding critically-ill adults cannot be properly translated
to children, it is imperative that this study is performed in this specific
population. The risk and burden of participation in this study is expected to
be minimal as compared to the risks and burden of usual clinical care for these
patients.
Meibergdreef 9
Amsterdam 1105 AZ
NL
Meibergdreef 9
Amsterdam 1105 AZ
NL
Listed location countries
Age
Inclusion criteria
Main study population:
- Age below 24 months
- Proven VLRTI
- Endotracheal intubation
- Mechanical ventilation
- Informed consent obtained for the complete study protocol (3 days) of
exposure to two different oxygen supplementation protocols on separate days
combined with non-invasive exhaled-breath measurements and a single
non-endoscopic bronchoalveolar lavage at the final day of study after
confirmation of comprehension of the Dutch language
Non-infected control population:
- Age below 12 years
- Endotracheal intubation
- Mechanical ventilation
- No signs of infection (fever, temperature >38.5 C) and no respiratory
symptoms (cough, wheeze, snotty) present at moment of intubation
- No reported respiratory symptoms in the last seven days prior to pediatric
intensive care unit admission
- Informed consent obtained for the partial study protocol (1 day) of exposure
to the liberal oxygenation protocol combined with non-invasive exhaled-breath
measurements after confirmation of comprehension of the Dutch language
Exclusion criteria
Main study population:
- Age above 24 months
- Active infection with SARS-CoV-2
- Contra-indication for high flow or low flow oxygen supplementation (e.g.
previous bleomycin treatment, carbon monoxide intoxication)
- No consent
- Receiving HFO
- Receiving nitric oxide treatment for pulmonary hypertension
- In need for specific oxygen saturation targets based on underlying congenital
heart disease
Non-infected control population:
- Age above 12 years
- Proven ongoing pulmonary infection
- Symptoms of a present or recent infection (temperature >38.5 C) or
respiratory symptoms (cough, wheeze, snotty) in the last seven days prior to
pediatric intensive care unit admission.
- Contra-indication for high flow oxygen supplementation (e.g. previous
bleomycin treatment)
- No consent
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL78024.000.21 |